Nonprofit · EIN 27-0425749
PREVENT ALZHEIMERS DISEASE 2020
Tax-exempt · POTOMAC, MD 20854
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $442,190 | $425,745 | $16,445 | $17,659 | $0 | $17,659 |
| December 31, 2023 | 990 | $357,136 | $471,717 | -$114,581 | $1,214 | $0 | $1,214 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $442,190
- Program service revenue
- $0
- Investment income
- $0
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $0
- Compensation of officers, directors and key employees
- $0
- Salaries, compensation and benefits (total)
- $0
- Professional fundraising fees
- $0
- Legal fees
- $20,543
- Accounting fees
- $18,720
- Occupancy
- $38,233
- Travel
- $22,323
- Program services (functional)
- $316,022
- Management and general (functional)
- $18,659
Balance sheet and other
- Total assets, start of year
- $1,214
- Total assets, end of year
- $17,659
- Total liabilities, end of year
- $0
- Net assets, end of year
- $17,659
- Gross receipts
- $442,190
- Employees
- 0
- Volunteers
- 80
- Year formed
- 2009
- State of legal domicile
- MD
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| ZAVEN KHACHATURIAN | CHAIR PRESIDENT Trustee or director, Officer | 20 | $0 |
| ARA KHACHATURIAN | EVP TREASURER Trustee or director, Officer | 20 | $0 |
| PETER SNYDER | DIRECTOR Trustee or director | 1 | $0 |
| KATE HAYDEN | DIRECTOR Trustee or director | 1 | $0 |
990 for the year ended December 31, 2023: 4 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| ZAVEN KHACHATURIAN | CHAIR PRESIDENT Trustee or director, Officer | 20 | $0 |
| ARA KHACHATURIAN | EVP TREASURER Trustee or director, Officer | 20 | $0 |
| PETER SNYDER | DIRECTOR Trustee or director | 1 | $0 |
| KATE HAYDEN | DIRECTOR Trustee or director | 1 | $0 |
Address and contacts
- Address (IRS master file)
- 9812 FALLS RD STE 114 PMB 155, POTOMAC, MD 20854-3963
- In care of
- % ARA KHACHATURIAN
- Mailing address (990-N for 2019)
- 451 HUNGERFORD DRIVE SUITE 119-355, ROCKVILLE MD 20854
- Principal officer (990 for 2024)
- ARA KHACHATURIAN, 9812 FALLS RD STE 114 155, POTOMAC, MD 20854
- Principal officer (990-N for 2019)
- ARA KHACHATURIAN, 451 Hungerford Drive, SUITE 119-355, ROCKVILLE MD 20854
- Signed the 990
- ARA KHACHATURIAN, Executive Vice President and Treas
- Phone
- (301) 309-6730
- Website
- WWW.PAD2020.ORG
Mission
PAD2020 was created to rally national support and focus on increasing research and knowledge to prevent Alzheimers disease and other neurodegenerative diseases that affect the memory movement or mood of individuals.
Program accomplishments
- In the United States two major regulatory hurdles must be overcome for affordable and accessible tools to be developed and deployed for diagnosing assessing and monitoring those at risk of or with cognitive disorders. The FDA and CMS have two different regulatory missions. Developers of new clinical interventions and tools must demonstrate the effectiveness and clinical relevance of their outcomes. They also need to consider factors such as reimbursement and quality. To address these challenges the Campaign to Prevent Alzheimers Disease launched a task force to review recommendations and develop new project proposals. The group titled The Campaign to Prevent Alzheimers Disease Work Group on Community-Based Detection and Assessment of Cognitive Decline, identified different pathways of community-based detection using electronic health records from different international healthcare systems to detect and monitor individuals with early cognitive impairment. The recommendations aim to guide future sustainability activities public policy campaigns and implementation pilots.Expenses $225,447 · grants $265,314
- Alzheimers disease poses a significant burden on a global scale which has led to an enormous investment in research to find a cure. However despite these efforts there are very few medications available for people with dementia. The search for new interventions for Alzheimers disease is challenging because the exact relationship between the symptoms of the disease and its neurobiology is not yet fully understood. The diseases heterogeneity complex biological and environmental interactions multiple nonlinear timescales and a lack of modeling systems to integrate complex relationships further complicate this effort. To address these challenges the Calcium System Theory of Alzheimers Disease CAST-AD workgroup aims to design a unified systems theory. The group aims to create new foundational models to study protein dynamics and aggregation in neurodegenerative diseases. These models will be trained using supercomputing and hybrid super- and quantum-computing to simulate large data sets of proteins. The project will establish and validate foundational models using proteins such as bioluminescent enzymes to provide an easy functional readout. The group will then apply these models to crucial proteins and peptides involved in neurodegenerative diseases.Expenses $41,514 · grants $65,000
- Brain vascular diseases are linked to the onset of dementia. PAD 20 20 coordinated a global task force to assess the efficacy of utilizing approved vascular health interventions to prevent or treat dementia. Evidence shows that modifying lifestyle factors such as physical activity healthy diet and proper sodium intake can improve vascular health and offer an opportunity for brain health. The initiative aims to identify tangible opportunities to provide financial or technical resources to sustain multi-year activities and evaluate approaches that may accelerate the development of new interventions. The project will focus on developing strategies to provide affordable accessible and equitable dementia prevention through widely prescribed medications for various vascular and metabolic disorders. There is a clear need for robust clinical evidence to support this public health approach.Expenses $49,061 · grants $70,000
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 27-0425749
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2009
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H83)
- Assets (IRS master file)
- $17,659
- Income (IRS master file)
- $442,190
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $442,190 | $425,745 | $17,659 | XML |
| 990 | December 2023 | $357,136 | $471,717 | $1,214 | XML |
| 990 | December 2022 | $631,438 | $521,200 | $115,795 | IRS |
| 990-EZ | December 2021 | – | – | – | IRS |
| 990-EZ | December 2020 | – | – | – | IRS |
| 990-N for 2019 Officer: ARA KHACHATURIAN | December 31, 2019 | ≤ $50,000 receipts | – | – | e-Postcard |
| 990-EZ | December 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 27-0425749).
Questions about PREVENT ALZHEIMERS DISEASE 2020
- What is the EIN of PREVENT ALZHEIMERS DISEASE 2020?
- The employer identification number (EIN) of PREVENT ALZHEIMERS DISEASE 2020 is 27-0425749.
- Is PREVENT ALZHEIMERS DISEASE 2020 tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2009.
- Are donations to PREVENT ALZHEIMERS DISEASE 2020 tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does PREVENT ALZHEIMERS DISEASE 2020 file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of PREVENT ALZHEIMERS DISEASE 2020 due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did PREVENT ALZHEIMERS DISEASE 2020 last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of PREVENT ALZHEIMERS DISEASE 2020?
- The 990 for the year ended December 31, 2024 names ARA KHACHATURIAN.
- Who are the officers and directors of PREVENT ALZHEIMERS DISEASE 2020?
- The 990 for the year ended December 31, 2024 lists 4 people; 0 received compensation from the organization.
- How much revenue does PREVENT ALZHEIMERS DISEASE 2020 have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $442,190, expenses of $425,745 and total assets of $17,659 at year end.
Other nonprofits in POTOMAC
- DETERMINED2HEAL FOUNDATION INC EIN 34-2054472 · last filed 990 for 2024
- CHINESE BIOPHARMACEUTICAL ASSOCIATION-USA INC EIN 75-2996955 · last filed 990 for 2025
- AN FAMILY FOUNDATION INC EIN 99-3407839 · last filed 990-PF for 2025
- SOUTH ASIAN PUBLIC HEALTH ASSOCIATION INCORPORATED EIN 04-3640744 · last filed 990-PF for 2024
- CHILDRENS RARE DISEASE ORGANIZATION INC EIN 86-1179378 · last filed 990 for 2025
- CORY HEIDARAN CHARITABLE FOUNDATION EIN 85-3887226 · last filed 990 for 2025
- TECHNOLOGY HELPING PEOPLE INC EIN 99-3443918 · last filed 990-N for 2025
- CHINESE AMERICAN SOCIETY OF NANOMEDICINE AND NANOBIOTECHNOLOGY EIN 47-4569200 · last filed 990-N for 2025